Biotech Firm Amorphical Reports Breakthrough in Crohn’s Disease Therapy
Israeli biotech Amorphical announces breakthrough Crohn’s therapy, achieving sustained remission with nano-amorphous Calcium Carbonate in Phase 2 trial at.
Israeli biotech Amorphical announces breakthrough Crohn’s therapy, achieving sustained remission with nano-amorphous Calcium Carbonate in Phase 2 trial at.